Marathon Asset Management Ltd Has $20.35 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Marathon Asset Management Ltd raised its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 3.2% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 279,203 shares of the company’s stock after purchasing an additional 8,742 shares during the quarter. Marathon Asset Management Ltd’s holdings in Henry Schein were worth $20,354,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Swedbank AB acquired a new stake in Henry Schein during the 1st quarter worth approximately $215,998,000. Thompson Siegel & Walmsley LLC bought a new position in Henry Schein during the 2nd quarter worth $46,683,000. SG Americas Securities LLC raised its holdings in Henry Schein by 1,622.3% in the 3rd quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock valued at $33,449,000 after acquiring an additional 432,187 shares in the last quarter. Nuance Investments LLC grew its holdings in shares of Henry Schein by 28.5% during the 1st quarter. Nuance Investments LLC now owns 1,755,190 shares of the company’s stock worth $132,552,000 after purchasing an additional 388,843 shares in the last quarter. Finally, Magnetar Financial LLC increased its position in shares of Henry Schein by 229.9% in the first quarter. Magnetar Financial LLC now owns 386,458 shares of the company’s stock worth $29,185,000 after purchasing an additional 269,330 shares during the period. 96.62% of the stock is owned by institutional investors.

Henry Schein Stock Performance

NASDAQ:HSIC opened at $71.67 on Friday. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $60.01 and a twelve month high of $82.63. The company has a fifty day moving average of $70.26 and a 200-day moving average of $69.90. The firm has a market capitalization of $9.18 billion, a P/E ratio of 24.21, a P/E/G ratio of 1.98 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. The firm had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The business’s quarterly revenue was up .0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.31 earnings per share. As a group, sell-side analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Analyst Upgrades and Downgrades

HSIC has been the topic of a number of analyst reports. Piper Sandler reiterated an “overweight” rating and set a $86.00 price objective on shares of Henry Schein in a research note on Friday, June 21st. Robert W. Baird cut their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Evercore ISI increased their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Barrington Research restated an “outperform” rating and set a $82.00 price objective on shares of Henry Schein in a research report on Friday, September 20th. Finally, Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. One investment analyst has rated the stock with a sell rating, six have given a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $77.50.

Insider Buying and Selling

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.14% of the stock is owned by company insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.